@article {3214, title = {Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.}, journal = {Journal of acquired immune deficiency syndromes (1999)}, volume = {56 Suppl 1}, year = {2011}, month = {2011 Mar 1}, pages = {S62-7}, abstract = {The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir.}, keywords = {Anti-HIV Agents, Buprenorphine, Cohort Studies, Dose-Response Relationship, Drug, Drug Interactions, Drug-Induced Liver Injury, HIV Infections, Humans, Naloxone, Oligopeptides, Opioid-Related Disorders, Pyridines}, issn = {1944-7884}, doi = {10.1182/blood-2011-06-362194}, author = {Vergara-Rodriguez, Pamela and Tozzi, Mary Jo and Botsko, Michael and Nandi, Vijay and Altice, Frederick and Egan, James E and O{\textquoteright}Connor, Patrick G and Sullivan, Lynn E and Fiellin, David A} }